Michelle Blake
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Bone health and treatments
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 8
- Bone health and treatments 4
- CAR-T cell therapy research 4
- Cytokine Signaling Pathways and Interactions 1
-
- Bone Metabolism and Diseases 4
- Co-authors
- William C. Dougall (3 shared papers)Mark Tometsko (4 shared papers)Jon C. Jones (3 shared papers)Robert E. Miller (3 shared papers)Stefan Größ (1 shared paper)Zenon Konteatis (1 shared paper)Jeremy Travins (1 shared paper)Phong Quang (1 shared paper)
- Journals
- Blood (4 papers)Cancer Research (1 paper)Journal of Thoracic Oncology (1 paper)Journal of Medical Economics (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- United StatesSouth AfricaCanada
In The Last Decade
Michelle Blake
10 papers receiving 652 citations
Peers
Comparison fields: 5 of 56
- Oncology 410
- Hematology 107
- Molecular Biology 442
- Cancer Research 86
- Immunology 71
Countries citing papers authored by Michelle Blake
This map shows the geographic impact of Michelle Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Blake more than expected).
Fields of papers citing papers by Michelle Blake
This network shows the impact of papers produced by Michelle Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Blake. The network helps show where Michelle Blake may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Blake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 280 | |
| 2 | 2018 | 101 | |
| 3 | 2018 | 88 | |
| 4 | 2019 | 50 | |
| 5 | 2013 | 49 | |
| 6 | 2015 | 41 | |
| 7 | 2014 | 33 | |
| 8 | 2019 | 22 | |
| 9 | 2011 | 4 | |
| 10 | 2025 | 2 | |
| 11 | 2023 | 0 |
About Michelle Blake
Michelle Blake is a scholar working on Oncology, Molecular Biology, Hematology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 670 indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), CAR-T cell therapy research (4 papers), Bone Metabolism and Diseases (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Multiple Myeloma Research and Treatments (3 papers), Bone health and osteoporosis research (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Oncology (410 citations), Hematology (107 citations), Molecular Biology (442 citations), Cancer Research (86 citations) and Immunology (71 citations). Michelle Blake has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include William C. Dougall, Mark Tometsko, Jon C. Jones, Robert E. Miller, Stefan Größ, Zenon Konteatis, Jeremy Travins, Phong Quang, Marion Dorsch and Michelle Clasquin. Their work appears in journals such as Blood, Cancer Research, Journal of Thoracic Oncology, Journal of Medical Economics and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.